laboratori corpor
remain bullish lh post mark decent lab result strong
cro trend highlight margin expans impress book-to-bil
solid cf modest guidanc trim patient satisfaction/retail effort
expand balanc sheet flexibl pama acceler
share gain opportun expect head wind
pama overarch driver remain strong lh differenti model
provid uniqu posit addit move toward valu base care
inher favor larg public reiter buy pt ep
friend expect challeng pama unh/
aet contract dynam buy /aet nr
believ diagnost lab industri remain key start point
drive massiv portion healthcar decis make addit lh
suprem posit scale low cost high qualiti provid healthcar
environ shift toward valu would also highlight lh
notic less govern pay exposur clinic lab segment mani
peer leav modestli expos on-going pama cut
cro segment provid increment diversif final expect
pama challeng drive share gain opportun acceler
lab result decent one event creat nois revenu
diagnost side came shi tie softer volum
impact coupl one item hurrican ransomwar
attack exclud event volum grew organ vs
price per requisit fell better estim
adjust oper incom margin yoy
pama one-tim event labor lh launch phase project launchpad
help allevi margin pressur drive oper effici
process autom facil optim implement new tool
off-set expect margin head wind
strong revenu nice ahead
y/i organ addit book-to bill impress
ttm book-to-bil improv sequenti net order increas
backlog exit expect
convert revenu next month lastli adjust oper margin
tr target
laboratori corpor america hold
continu expand improv yoy bp sequenti bp launchpad savings/
rais bar patient convenience/satisfact initi labcorp continu
aggress advanc retail strategi recent announc expans labcorp
walgreen hold collabor store next four year today initi
result encourag uptick new patient number increas user satisfact
addit compani tee commerci launch conveni well test
offer sampl collect anywher home person on-line result initi
launch focus test area well chronic metabol ill optimist
addit potenti area roll-out given provid increment patient access/touch
point user conveni lastli lh continu expand portfolio efficiency/access tool
labcorp express labcorp pre-check labcorp patient expect drive oper
improv patient satisfact time
result net revenu shi estim tie
one item bp hurricane/ransomwar discuss advers foreign currenc
translat bp adjust ebit also came bit short estim
margin expans covanc off-set diagnost busi drive adjust
ebit margin vs strhe final adjust ep miss
tie non-cor event
balanc sheet solid cffo came
think strhe shortfal larg tie work capit time
discretionari pension contribut busi disrupt expect like benefit
wc time revers lh bought back stock net-debt-to-ltm ebitda
quarter end continu view financi flexibl high addit manag expect
deploy cash matur debt tax payment food solut sale
share repurchases/strateg acquisit remaind full-year guidanc mid-
point cut vs prior larg tie expect tax payment relat
food solut busi sale previou guidanc
guidanc trim adjust estim compani revis full year guidanc follow
 revenu growth vs diagnost revenu growth vs
covanc revenu growth vs adjust ep
lower full year ep estim
reflect non-cor event
overal result updat guidanc
page
laboratori corpor america hold
servic
revenu
incom equiti invest
revenu
laboratori corpor america mm
page
laboratori corpor america hold
headquart burlington nc laboratori corpor america hold labcorp one
largest independ clinic laboratori broad offer includ routin test
blood chemistri urinalys pap hiv substance-abus etc specialti test oncolog hiv
genotyp phenotyp diagnost genet clinic research trial compani also
opper cro busi extend servic offer includ clinic research provid
meaning intern presenc recent chiltern acquisit expand cro servic
clinic lab remain integr part healthcar deliveri model diagnost test critic
compon treatment decis process combin covanc busi lh boast
signific scale divers servic offer uniqu posit area person medicin
potenti risk-bas reimburs system diversifi revenu stream custom
base also meaning lower reimburs risk one custom repres revenu
govern pay addit signific clinic horsepow geograph
diversif provid platform addit growth opportun time
valuat risk
price target base stock trade adjust ep premium
current multipl industri peer hold given labcorp sizabl esoter presenc
solid cash flow gener attract cross-sel opportun covance/chiltern view
appropri addit believ effici initi aggress focu cost
control could provid support risk rate price target includ advers shift
reimburs pama poor integr acquisit pressur econom uncertainti
perform covanc increas competit
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
